Sfoglia per Afferenza Dipartimento di Scienze cliniche applicate e biotecnologiche
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers
2016-01-01 Ruscitti, Piero; Cipriani, Paola; Ciccia, F; Masedu, Francesco; Iacono, D; Guggino, G; Carubbi, Francesco; Berardicurti, O; DI BENEDETTO, Paola; Valenti, Marco; Triolo, G; Valentini, Gabriele; Giacomelli, Roberto; Liakouli, Vasiliki
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers
2016-01-01 Ruscitti, Piero; Cipriani, Paola; Masedu, Francesco; Liakouli, Vasiliki; Carubbi, Francesco; Berardicurti, Onorina; Guggino, Giuliana; DI BENEDETTO, Paola; Di Bartolomeo, Salvatore; Valenti, Marco; Triolo, Giovanni; Giacomelli, Roberto
Prognostic factors of survival in patients with advanced cancer admitted to home care
2013-01-01 Mercadante, Sebastiano; Valle, Alessandro; Porzio, Giampiero; Aielli, Federica; Adile, Claudio; Casuccio, Alessandra
Prognostic Factors: Molecular Pathway – Tumour Suppressor Gene (MEN1)
2018-01-01 Jaffrain-Rea, Marie-Lise; Rostomyan, Liliya; Beckers, Albert
Prognostic implications of tumor invasion or adhesion to peripancreatic vessels in resected pancreatic cancer
2009-01-01 Boggi, Ugo; DEL CHIARO, M; Croce, C; Vistoli, Fabio; Signori, S; Moretto, C; Amorese, G; Mazzeo, S; Cappelli, C; Campani, Daniela; Mosca, F.
PROGNOSTIC IMPLICATIONS OF VASCULAR INFILTRATION IN PANCREAS CANCER
2004-01-01 Boggi, Ugo; Del Chiaro, M; Croce, C; Gremmo, F; Marangoni, G; Sgambelluri, F; Vistoli, Fabio; Signori, S; Campatelli, A; DI CANDIO, Giulio; Mazzeo, S; Cappelli, C; Campani, Daniela; Bevilacqua, Generoso; Mosca, F.
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis
2023-01-01 Abdelhak, Ahmed; Barba, Lorenzo; Romoli, Michele; Benkert, Pascal; Conversi, Francesco; D'Anna, Lucio; Masvekar, Ruturaj R; Bielekova, Bibiana; Prudencio, Mercedes; Petrucelli, Leonard; Meschia, James F; Erben, Young; Furlan, Roberto; De Lorenzo, Rebecca; Mandelli, Alessandra; Sutter, Raoul; Hert, Lisa; Epple, Varenka; Marastoni, Damiano; Sellner, Johann; Steinacker, Petra; Aamodt, Anne Hege; Heggelund, Lars; Dyrhol-Riise, Anne Margarita; Virhammar, Johan; Fällmar, David; Rostami, Elham; Kumlien, Eva; Blennow, Kaj; Zetterberg, Henrik; Tumani, Hayrettin; Sacco, Simona; Green, Ari J; Otto, Markus; Kuhle, Jens; Ornello, Raffaele; Foschi, Matteo; Abu-Rumeileh, Samir
Prognostic relevance of Hormonal Receptor positive Status in HER2-positive Metastatic Breast Cancer Patients: Retrospective Analysis in Real Life
2015-01-01 Rinaldi, L.; Cannita, K.; Cocciolone, V.; Lanfiuti Baldi, P.; Irelli, A.; Paradisi, S.; Bruera, G.; Cortellini, A.; Ficorella, C.; Ricevuto, E.
Prognostic relevance of KRAS genotype and the prevalent C.35 G > a mutation in metastatic colorectal cancer (MCRC) patients fitting for intensive FIr-B/FOx triplet chemotherapy plus bevacizumab
2014-01-01 Cannita, K; Tessitore, Alessandra; Cortellini, A; Sabourin, Jc; Tosi, M; Frébourg, T; Alesse, E; Ficorella, C; Ricevuto, Enrico
Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen
2014-01-01 Bruera, G; Cannita, K; Giordano, Av; Vicentini, R; Ficorella, Corrado; Ricevuto, Enrico
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel
2016-01-01 Cocciolone, Valentina; Tessitore, Alessandra; Ricevuto, Enrico; Mastroiaco, Valentina; Rinaldi, Lucia; Paradisi, Stefania; Irelli, Azzurra; Sidoni, T; Dal Mas, A; Coletti, G; Ciccozzi, A; Resta, V; Bafile, A; Alesse, Edoardo; Ficorella, Corrado; Cannita, K.
Prognostic significance of CD68+ and CD163+ tumor associated macrophages in head and neck squamous cell carcinoma: A systematic review and meta-analysis
2019-01-01 Troiano, G.; Caponio, V. C. A.; Adipietro, I.; Tepedino, M.; Santoro, R.; Laino, L.; Lo Russo, L.; Cirillo, N.; Lo Muzio, L.
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis.
2017-01-01 Cocciolone, V; Cannita, K; Calandrella, Ml; Ricevuto, E; Baldi, Pl; Sidoni, T; Irelli, A; Paradisi, S; Pizzorno, L; Resta, V; Bafile, A; Alesse, E; Tessitore, A; Ficorella, C
Prognostic significance of p53 gene mutations in primary gastric carcinoma.
1994-01-01 Ricevuto, E; Martinotti, S; Fusco, C; Sinopoli, Nt; Marchetti, P; Toniato, E; Gabriele, A; Vittorini, C; Guadagni, S; Frati, L; Gulino, A; Ficorella, C.
Prognostic significance of P53 mutations in high risk node positive breast cancer patients
2000-01-01 Cannita, K; Ricevuto, Enrico; DE GALITIIS, Federica; DI ROCCO, ZORIKA CHRISTIANA; Tessitore, Alessandra; Porzio, Giampiero; Ficorella, Corrado; Marchetti, Paolo
Prognostic significance of presence and reduplication of basal lamina in malignant pleural mesothelioma
2000-01-01 Di Muzio, M.; Spoletini, L.; Strizzi, L.; Vianale, G.; Fontana, V.; Orengo, M. A.; Tassi, G.; Casalini, A.; Mutti, L.; Procopio, A.
Prognostic value of brain tissues’ volumes in patients with essential tremor treated with MRgFUS thalamotomy
2021-01-01 Tommasino, E.; Bruno, F.; Catalucci, A.; Varrassi, M.; Sucapane, P.; Cerone, D.; Pistoia, F.; Di Cesare, E.; Barile, A.; Ricci, A.; Marini, C.; Masciocchi, C.; Splendiani, A.
Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease
2012-01-01 Bruera, G; Cannita, K; Di Giacomo, D; Lamy, A; Troncone, G; Dal Mas, A; Coletti, G; Frebourg, T; Sabourin, Jc; Tosi, M; Ficorella, Corrado; Ricevuto, Enrico
Prognostic value of p53 molecular status in high-risk primary breast cancer
2003-01-01 Marchetti, P; Cannita, K; Ricevuto, Enrico; De Galitiis, F; Di Rocco, Zc; Tessitore, Alessandra; Bisegna, R; Porzio, G; De Rubeis, Gp; Ventura, T; Martinotti, S; Ficorella, Corrado
PROGNOSTIC VALUE OF TP53, CDKN2A/P16 AND SMAD4/ DPC4 IN LOCALLY ADVANCED, BUT RESECTED, PANCREATIC CANCER
2020-01-01 Napoli, N.; Kauffmann, E. F.; Cacace, C.; Menonna, F.; Cacciato Insilla, A.; Cappelli, C.; Vistoli, F.; Caramella, D.; Campani, D.; Boggi, U.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers | 1-gen-2016 | Ruscitti, Piero; Cipriani, Paola; Ciccia, F; Masedu, Francesco; Iacono, D; Guggino, G; Carubbi, Francesco; Berardicurti, O; DI BENEDETTO, Paola; Valenti, Marco; Triolo, G; Valentini, Gabriele; Giacomelli, Roberto; Liakouli, Vasiliki | |
| Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers | 1-gen-2016 | Ruscitti, Piero; Cipriani, Paola; Masedu, Francesco; Liakouli, Vasiliki; Carubbi, Francesco; Berardicurti, Onorina; Guggino, Giuliana; DI BENEDETTO, Paola; Di Bartolomeo, Salvatore; Valenti, Marco; Triolo, Giovanni; Giacomelli, Roberto | |
| Prognostic factors of survival in patients with advanced cancer admitted to home care | 1-gen-2013 | Mercadante, Sebastiano; Valle, Alessandro; Porzio, Giampiero; Aielli, Federica; Adile, Claudio; Casuccio, Alessandra | |
| Prognostic Factors: Molecular Pathway – Tumour Suppressor Gene (MEN1) | 1-gen-2018 | Jaffrain-Rea, Marie-Lise; Rostomyan, Liliya; Beckers, Albert | |
| Prognostic implications of tumor invasion or adhesion to peripancreatic vessels in resected pancreatic cancer | 1-gen-2009 | Boggi, Ugo; DEL CHIARO, M; Croce, C; Vistoli, Fabio; Signori, S; Moretto, C; Amorese, G; Mazzeo, S; Cappelli, C; Campani, Daniela; Mosca, F. | |
| PROGNOSTIC IMPLICATIONS OF VASCULAR INFILTRATION IN PANCREAS CANCER | 1-gen-2004 | Boggi, Ugo; Del Chiaro, M; Croce, C; Gremmo, F; Marangoni, G; Sgambelluri, F; Vistoli, Fabio; Signori, S; Campatelli, A; DI CANDIO, Giulio; Mazzeo, S; Cappelli, C; Campani, Daniela; Bevilacqua, Generoso; Mosca, F. | |
| Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis | 1-gen-2023 | Abdelhak, Ahmed; Barba, Lorenzo; Romoli, Michele; Benkert, Pascal; Conversi, Francesco; D'Anna, Lucio; Masvekar, Ruturaj R; Bielekova, Bibiana; Prudencio, Mercedes; Petrucelli, Leonard; Meschia, James F; Erben, Young; Furlan, Roberto; De Lorenzo, Rebecca; Mandelli, Alessandra; Sutter, Raoul; Hert, Lisa; Epple, Varenka; Marastoni, Damiano; Sellner, Johann; Steinacker, Petra; Aamodt, Anne Hege; Heggelund, Lars; Dyrhol-Riise, Anne Margarita; Virhammar, Johan; Fällmar, David; Rostami, Elham; Kumlien, Eva; Blennow, Kaj; Zetterberg, Henrik; Tumani, Hayrettin; Sacco, Simona; Green, Ari J; Otto, Markus; Kuhle, Jens; Ornello, Raffaele; Foschi, Matteo; Abu-Rumeileh, Samir | |
| Prognostic relevance of Hormonal Receptor positive Status in HER2-positive Metastatic Breast Cancer Patients: Retrospective Analysis in Real Life | 1-gen-2015 | Rinaldi, L.; Cannita, K.; Cocciolone, V.; Lanfiuti Baldi, P.; Irelli, A.; Paradisi, S.; Bruera, G.; Cortellini, A.; Ficorella, C.; Ricevuto, E. | |
| Prognostic relevance of KRAS genotype and the prevalent C.35 G > a mutation in metastatic colorectal cancer (MCRC) patients fitting for intensive FIr-B/FOx triplet chemotherapy plus bevacizumab | 1-gen-2014 | Cannita, K; Tessitore, Alessandra; Cortellini, A; Sabourin, Jc; Tosi, M; Frébourg, T; Alesse, E; Ficorella, C; Ricevuto, Enrico | |
| Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen | 1-gen-2014 | Bruera, G; Cannita, K; Giordano, Av; Vicentini, R; Ficorella, Corrado; Ricevuto, Enrico | |
| Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel | 1-gen-2016 | Cocciolone, Valentina; Tessitore, Alessandra; Ricevuto, Enrico; Mastroiaco, Valentina; Rinaldi, Lucia; Paradisi, Stefania; Irelli, Azzurra; Sidoni, T; Dal Mas, A; Coletti, G; Ciccozzi, A; Resta, V; Bafile, A; Alesse, Edoardo; Ficorella, Corrado; Cannita, K. | |
| Prognostic significance of CD68+ and CD163+ tumor associated macrophages in head and neck squamous cell carcinoma: A systematic review and meta-analysis | 1-gen-2019 | Troiano, G.; Caponio, V. C. A.; Adipietro, I.; Tepedino, M.; Santoro, R.; Laino, L.; Lo Russo, L.; Cirillo, N.; Lo Muzio, L. | |
| Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. | 1-gen-2017 | Cocciolone, V; Cannita, K; Calandrella, Ml; Ricevuto, E; Baldi, Pl; Sidoni, T; Irelli, A; Paradisi, S; Pizzorno, L; Resta, V; Bafile, A; Alesse, E; Tessitore, A; Ficorella, C | |
| Prognostic significance of p53 gene mutations in primary gastric carcinoma. | 1-gen-1994 | Ricevuto, E; Martinotti, S; Fusco, C; Sinopoli, Nt; Marchetti, P; Toniato, E; Gabriele, A; Vittorini, C; Guadagni, S; Frati, L; Gulino, A; Ficorella, C. | |
| Prognostic significance of P53 mutations in high risk node positive breast cancer patients | 1-gen-2000 | Cannita, K; Ricevuto, Enrico; DE GALITIIS, Federica; DI ROCCO, ZORIKA CHRISTIANA; Tessitore, Alessandra; Porzio, Giampiero; Ficorella, Corrado; Marchetti, Paolo | |
| Prognostic significance of presence and reduplication of basal lamina in malignant pleural mesothelioma | 1-gen-2000 | Di Muzio, M.; Spoletini, L.; Strizzi, L.; Vianale, G.; Fontana, V.; Orengo, M. A.; Tassi, G.; Casalini, A.; Mutti, L.; Procopio, A. | |
| Prognostic value of brain tissues’ volumes in patients with essential tremor treated with MRgFUS thalamotomy | 1-gen-2021 | Tommasino, E.; Bruno, F.; Catalucci, A.; Varrassi, M.; Sucapane, P.; Cerone, D.; Pistoia, F.; Di Cesare, E.; Barile, A.; Ricci, A.; Marini, C.; Masciocchi, C.; Splendiani, A. | |
| Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease | 1-gen-2012 | Bruera, G; Cannita, K; Di Giacomo, D; Lamy, A; Troncone, G; Dal Mas, A; Coletti, G; Frebourg, T; Sabourin, Jc; Tosi, M; Ficorella, Corrado; Ricevuto, Enrico | |
| Prognostic value of p53 molecular status in high-risk primary breast cancer | 1-gen-2003 | Marchetti, P; Cannita, K; Ricevuto, Enrico; De Galitiis, F; Di Rocco, Zc; Tessitore, Alessandra; Bisegna, R; Porzio, G; De Rubeis, Gp; Ventura, T; Martinotti, S; Ficorella, Corrado | |
| PROGNOSTIC VALUE OF TP53, CDKN2A/P16 AND SMAD4/ DPC4 IN LOCALLY ADVANCED, BUT RESECTED, PANCREATIC CANCER | 1-gen-2020 | Napoli, N.; Kauffmann, E. F.; Cacace, C.; Menonna, F.; Cacciato Insilla, A.; Cappelli, C.; Vistoli, F.; Caramella, D.; Campani, D.; Boggi, U. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile